---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-025744"
form_type: "8-K"
ticker: "IDXG"
cik: "0001054102"
company_name: "INTERPACE BIOSCIENCES, INC."
filed_at: "2021-10-19T23:59:59+00:00"
generated_at: "2026-06-28T19:51:24.398053+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Interpace Biosciences enters $7.5M revolving credit facility with Comerica Bank

## Summary
- Credit facility of up to $7.5M, matures September 30, 2023, secured by substantially all assets.
- Advances based on 80% of eligible accounts receivable plus $2M non-formula availability stepping down $250K/quarter.
- Interest rate equals prime plus 0.50% (prime is greater of Comerica's rate or daily LIBOR + 2.5%).
- Existing $7.5M bridge loans from private equity investors subordinated to Comerica's first-priority lien.
- Proceeds for working capital and general corporate purposes; unused facility fee of 0.25% per annum.

## SEC filing metadata
- accession: 0001493152-21-025744
- form_type: 8-K
- ticker: IDXG
- cik: 0001054102
- company_name: INTERPACE BIOSCIENCES, INC.
- filed_at: 2021-10-19T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1054102/000149315221025744/0001493152-21-025744-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1054102/000149315221025744/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-025744
- JSON: https://secwatch.observer/filing/0001493152-21-025744.json
- Plain text: https://secwatch.observer/filing/0001493152-21-025744.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.